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Trends and challenges in preventive medicine
in European Union countries. Comment on the state
in Croatia.
INTRODUCTION. HISTORICAL FRAMEWORK
OF PREVENTIVE MEDICINE AND PUBLIC HEALTH
Throughout history, major contributions to population health havecome from the initiatives of public health and community-based
activities, such as improvements in food supplies and nutrition, sani-
tary and general living conditions, vaccinations and smoking cessation
campaigns. However, the importance of these public measures has not
always been corectly verified by the medical establishment, tradition-
ally focused on curing ill individuals. Public health care services have
been considered as being too close to social measures and politics and
lacking in experimental, scientific methods. In contrast, clinical medi-
cine has been established early on as a branch of science, being oriented
towards both, searching for pathogenetic causes of diseases and the sci-
entifically-based treatment (1).
Public health has become more scientifically based during the later
part of the 19th and the first part of the 20th century, due to the efforts of
Robert Koch and Louis Paster. During that time, huge advances in un-
derstanding the nature of infectious diseases and their ways of spread-
ing and prevention have been achieved. Dramatic success in the eradi-
cation of many dangerous infectious diseases through vaccination and
the definition of microbial agents as biological causes of infectious dis-
eases has initiated the strong biological orientation in epidemiology
and other public health settings (2,3). This has led to the development
of experimental research methodologies with focus placed on statistical
issues. Many characteristics of modern epidemiology and other public
health settings, viewed as a part of science, have their roots in this
»golden era«. Analysts agree that these characteristics can be described
as an expansion of statistical methods for the measurement of the
occurence of diseases in the population. However, by using conven-
tional methods of analysis, diseases are excluded from their natural so-
cial and historical context (1).
Nevertheless, this was the time of the industrial revolution in west-
ern countries which uncovered the importance of socioeconomic fac-
tors as implicated in disease onset and the distribution pattern. Ideas on
social medicine and public health in historical terms appear in two di-
rections. The first one is conviction that social, environmental and eco-
nomic condition influence health. The second one is that for the solu-
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Overview
control of diseases collective actions are needed. For
those collective actions, the main responsibility should
take public authorities. Public health as defined by CEA
Winslow in 1920 started in 19th century (4).
Since that time the modern ideas of public health be-
gan to be implemented in everyday practice in countries
of South Eastern European Region (SEE) which were
under different influence, either from the West or East.
Slovenia, Croatia and Bosnia and Herzegovina were
mostly linked to Western Europe, and Serbia and Monte-
negro, Bulgaria, Macedonia, Romania, and Moldova
were mostly linked to Russia and Soviet Union. That fact
had, and even now has, the consequences for the devel-
opment of public health, organization of health services
and health care in this region (5).
The most prominent public health person in the SEE
region in the second part of the 19th century and begin-
ning of the 20th century was Milan Jovanovi}-Batut
(1847–1940) born in Srijemska Mitrovica, Vojvodina
(Serbia). He was the public health educator, writer,
teacher and health reformer. His work has great impact
on the development of public health in the region. His
student and successor was Andrija [tampar (1888-1958),
born in the village Drenovac (Croatia), on the border of
the then Austro-Hungarian Monarchy. Very early in his
life he was exposed to poverty, inequality and injustice of
life of rural people. Among other scientists who influ-
enced [tampar by their outlook, special attention should
be made of the biologist Ernst Haeckel and Alfred
Grotjahn. Social influences to health [tampar experi-
enced and undertaken interventions very intense in
countries of former Yugoslavia and China during 30-ties
of the last century (5).
TRENDS IN MODERN MEDICINE AND
PUBLIC HEALTH
Deepening the schism between clinical
medicine and public health
The modern era of medicine and public health is
characterized by a domination of chronic noncommuni-
cable diseases in morbidity and mortality causes, par-
tially as a consequence of the decline in infectious dis-
eases and partially related to modern lifestyle regarding
the urban congestion and technology boom. Based on
such background, the schism between medicine and
public health has been exacerbated (1, 3).
The growing demand to treat complicated chronic
diseases has resulted in the expansion of hospitals and
other health care facilities. New diagnostic and treat-
ment approaches have been developed. Funds for medi-
cal research and total resources in the health care sector
have dramatically increased. Clinical medicine, regard-
ing this situation, has become extremely specialized and,
as a consequence, narrowly focused (3). In its research
base, clinical medicine has concentrated on the study of
biological mechanisms of diseases and pharmacological
treatment, linking the objects of interest more closely to
basic sciences, technological innovation and treatment,
than to the primary prevention of diseases. In this way,
the historical dichotomy between clinical medicine and
public health has increased, emphasizing the separation
of health care on individually-based and population-
based approaches (1, 6).
The risk factor paradigm in prediction
and prevention of chronic
noncommunicable diseases
Public health has been faced with a renewed demand
for protecting the public against diseases. This time, the
goal was to indentify risk factors for chronic noncommu-
nicable diseases and then to eliminate them through ef-
fective preventive measures. This approach is due to the
fact that complex chronic diseases are multifactorially
caused. That means that there is no known cause for a
disease, but multiple factors contribute to the develop-
ment of a disease (1, 7).
Risk factors for cardiovascular diseases were defined as:
hypertension, hypercholesterolemia, hyperglycemia, obe-
sity, smoking and sedentary lifestyle (8). The discovery of
smoking tobacco as a factor strongly associated with lung
cancer has further emphasized the paradigm of risk factors
approach. Subsequently, many other chemicals with their
source in industry, agriculture, general environment, food
and consumer products, have been defined as external fac-
tors which may contribute to the occurence of cancer
(termed carcinogens). These factors, also including ioniz-
ing radiation and some syntetically produced drugs, can
be supposed as the by-products of advanced technology
and environmental pollution (9, 10).
During the time, it has been recognized that many be-
havioural risk factors, such as obesity, low physical activ-
ity, smoking, high fat and low fruit and vegetable intake,
as well as cumulative stress from various social circum-
stances, can lead to the development of both cardiovascu-
lar diseases and cancer, most likely operating through
shared patophysiologic pathways (11).
The expansion of preventive actions
and programmes. Evidence-based
guidelines and recommendations
Successes of the risk factor epidemiology have led to
the implementation of a wide-range of preventive inter-
ventions, including: legislative measures to restrict to-
bacco advertising and smoking in public places, health
education activities for problems such as obesity or low
physical activity, community campaigns for checking
high blood presssure, early cancer detection, immuniza-
tion against influenza, city programmes on initiatives
such as bike-paths and parks encouraging physical activ-
ity etc. In general, preventive activities can be performed
in individual terms and population terms, regarding spe-
cific groups, local communities or encompassing the en-
tire population (1, 3).
Based on the results of epidemiologic studies and sub-
sequent meta-analyses, EU member states tend to har-
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monize guidelines on the prevention of atherosclerotic
vascular diseases (12). In some countries, comprehensive
programmes on the reduction of the burden of cardiovas-
cular diseases and their horrible consequences have been
implemented (13). Some respective international agen-
cies have prepared recommendations aimed towards the
prevention of cancer. Recommendations are based on the
estimation that up to one third of cancer cases can be pre-
vented merely by implementation of the principles of
healthy lifestyles, by means of a healthy diet, regular
physical activity, no smoking and non excessive alcohol
consumption. Even better results could be expected if
other preventive measures, known to deal with the re-
duction of total cancer incidence, were systematically ap-
plied, including: methods of protection from sexually
transmitted diseases, immunization against Human
Papilloma Virus and Hepatitis B Virus infection, strictly
implemented legislation on the control of occupational
carcinogens and avoidance of cancer-causing substances
in the global environment (11, 14). In addition, the expe-
rience of countries where the national programmes of
early detection of particular common cancer sites have
been implemented, confirms that this approach is the
most effective and, in the long run, the least costly
method for fighting against cancer (15). Recently, an
awareness has been growing up that more integrated ini-
tiatives are needed in order to achieve overall chronic dis-
ease control. Low income and developing countries,
dealing with a growing chronic disease burden, should
also be included and especially supported (16).
The information system
In many EU countries, the information system and
the electronic health record has been installed to support
practice in the health care system. The emphasis is on as-
suring that data are collected for administrative purposes
and health statistics and exchanged between various de-
partments within the system. However, it is expected that
in the near future the information system will provide
support for quality improvement, practice-based re-
search and the generation of new knowledge (17, 18).
The Internet has created new opportunities in dissemi-
nating information relevant for behavioral interventions.
In particular, early results on computer-tailored preven-
tion programmes are encouraging. In this way, respon-
dents are provided with personally adapted feedback on
their present health state and suggestions for change (19,
20). Website-delivered guidelines and evidence-based
recommendations help physicians in clinical deci-
sion-making, support continuous learning and improve
their professional capabilities (17).
Progress in biotechnology.
Personalized medicine
The enormous progress in biotechnology, during the
last decades, has been expected to provide benefits by im-
plementing genomics, proteomics and other new sophis-
ticated techniques in health care practice and chronic
disease prevention (21, 22). Scientific advances have
made it possible to diagnose many chronic diseases, no-
tably cancers, much earlier than before (22, 23). The
great opportunity is also in customizing drug therapy by
selecting the best treatment and the right dosage and
minimizing the side effects of drugs (24, 25). The respec-
tive molecular methods include testing for genetic risk
profiles that identifies the individual's risk for various
diseases and drug responses as well as testing on
proteomic patterns in a serum that can distinguish indi-
viduals according to their specific physiology and metab-
olism (21, 22). These new approaches stimulate the
adoption of personalized medicine in the health care
practice (25). Other promising areas are nutrigenetics
(asks the question how individual genetic disposition af-
fects susceptibility to diet) and nutrigenomics (asks the
question how diet influences gene transcription, protein
expression and metabolism) having the potential to pro-
vide the basis for personalized nutrition (21, 26). Knowl-
edge about this could be important when planning the
primary and secondary prevention of common multi-
factorial diseases. Moreover, modern approaches in nu-
trition are expected to be focused on health promotion,
improving health performances of individuals long be-
fore early signs of disorders are manifested (25, 26).
Dilemmas connected to biotech
advances
A rapid progression of biotechnology raises a number
of issues on the value of practical applications of new ap-
proaches beyond the scope of more traditional ones (22).
There is a fear of widening the schism between medicine
and public health, as the technologically driven healthcare
system shifts the attention from the social and environ-
mental causes of diseases to the individual level and the
»blaming the victim« paradigm. The direct result is the
clear separation between public health interventions and
the prevention of high-risk individuals (1, 27). Another
question is whether or not testing, e.g. genetic traits, is
needed to target interventions even at the individual level.
In individuals testing negative, this may reduce motiva-
tion to change unfavourable behaviour. Also, in cases with
positive family history, e.g. on cancer, it is questionable if
genetic testing can add value to profile disease risk pro-
vided only by a family history (22). These and similar di-
lemmas are further complicated by the fact that the intro-
duction of technological improvements in real life
increases the costs of health care delivery and, therefore,
potentiates inequties in access to health care (1, 27).
On the other hand, many analysts suppose that the
»omics era« is the right framework to bring medicine and
public health together as partners (27). This is supported
by the evidence that information obtained from e.g. test-
ing for individual genetic risk profile is generally lacking
on the analytic and clinical validity. To assess the clinical
utility of genetic tests, evaluation of these tests from the
population perspective is needed, estimating their rela-
tive contribution to disease occurence in different groups
or the population as a whole. In this context, information
is required on: the prevalence of high-risk genetic vari-
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ants in the population of interest, the strength of the as-
sociation between these variants and a disease under in-
vestigation and interactions between these genetic
variants and other genetic and environmental factors. In
this way, genetic (biologic) and epidemiologic (popula-
tion) methods tend to converge onto the common frame-
work (22, 27).
Although numerous tests based on discoveries in
genomics and proteomics are available for practical pur-
poses, they are not ready for routine applications (22).
Nevertheless, advances in molecular biology have pointed
out a need for transdisciplinary research, including basic
sciences, clinical medicine, public health, social sciences,
bioethics and policy making, in order to effectively man-
age the dominant issues in health care today (3, 27).
Crisis of methodology
The ongoing debate in research is whether the avail-
able methodological tools are appropriate for studying
chronic noncommunicable diseases. Shortly, although
much efforts has been done on research into causes of
chronic complex diseases, a little progress has been
achieved in answering the question who will be affected.
Analysts agree that possible reasons include the use of
methods that have arisen from experimental sciences.
They are based on the philosophical postulates of ratio-
nalism, by means of reductionistic search for the cause of
a disease (6, 7). The leading concept of a study design to-
day, »case-control« concept, takes randomization as a
technique to control confounding factors. This concept
is based on a paradigm of the dichotomy between health
and disease. This is not appropriate for studying chronic
complex diseases, because they are characterized by mul-
tiple causal factors, each having a weak effect. In addi-
tion, there is a gradual changing pathway from health to
disease (1, 7).
There are some other methodological discordances.
The risk factor paradigm, used in the probabilistic esti-
mation, is defined at the individual level but analysed at
the population level. As a result, the individual's risk can-
not be predicted with certainty from group data (ex-
pressed by means of the population average) (1, 6). Fur-
ther, each risk factor is treated as having a high predictive
power (strong effect). Ongoing preventive actions are
based on such an assumption (assuming, e.g., that al-
most all smokers will develop lung cancer) (6). Both,
conceptualization of risk factors in individual terms and
reductionist thinking in research, has led to a lifestyle ap-
proach in preventive strategies and medicalization of
treatment (drugs for lowering high blood lipids and high
blood pressure), avoiding questions on social and cul-
tural determinants of diseases (1, 6). In contrast, it is well
documented that healthy lifestyles arise automatically
from the ability of a given social environment to allow
humanistic and safe everyday life for the majority of its
citizens (6).
The reductionist search for the cause of a disease, on
the other hand, has led to numerous investigations in ge-
netics (24). The idea was to find more detailed causes of
diseases (7). Finally, it has been recognized that the factors
used to explain the cause of diseases can operate at differ-
ent levels of analysis, including molecular, individual and
population. A general notion in the research community is
that the factors from all levels should be incorporated in
assessing individual's risk. Alternatively, the emphasize
should be put on using the methodology appropriate for
the level of studying, rather than studying factors that fit
the method, as is the current situation (1, 6, 7).
There are other reasons why the risk factor paradigm
does not seem to be a scientifically justified strategy for
studying complex chronic diseases. One of them is an ob-
servation from a cardiovascular risk factor analysis on the
high prevalence of risk factors in the general population
(60%-90%), independently of whether the group of ill
people is considered, or if it is a matter of the control (6).
In addition, there is a high heterogeneity (varying com-
bination) of risk factors among people in the population.
Exposures to environmental factors are dynamic, chang-
ing in number, intensity and combination (7). However,
except for some theoretical considerations, there is not an
alternative to the classical methodology approach (28)
CHALLENGES FOR THE FUTURE.
STRIVING FOR THE PATNERSHIP
BETWEEN CLINICAL MEDICINE AND
PUBLIC HEALTH
The current state of the health care system can be
summarized as follows: fragmentation on poorly coordi-
nated disciplines, clear separation of clinical medicine
and public health and new diagnostic and treatment op-
portunities based on advances in health care technology
and biotechnology (Figure 1). This is followed by a rise
in health care costs and the disparity in access to the
health care system (1, 3). In addition, there is a claim for
a more personalized approach in risk profile assessment,
prevention and treatment, while, at the same time, an ex-
pansion of separate community health campaigns can be
registred (22, 25).
The current state of research can be described as: con-
fusion in designing observational studies of causality by
means of the lack of associations between the knowledge
about the biologic mechanisms which underlie diseases
and the observed differences in the distribution pattern
of chronic diseases across the population, dogmatism in
data analysis methods and the lack of alternative ap-
proaches (1, 6, 7). The growing evidence indicating the
biological complexity of common chronic diseases corre-
lates with the increasing number of theoreticians en-
gaged in chaos theory and non-linear mathematical
modeling (29, 30). An attempt to provide care based on
scientific evidence (evidence-based medicine) meets the
problem of how to translate the results of the clinical
studies, expressed in terms of the average values of stud-
ied groups, to be applied to the specific situation of an in-
dividual. Also, the challenge is how to integrate knowl-
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edge on the mechanisms underlying diseases in the
holostic vision of a patient as a whole (6, 7, 31).
In primary health care, there is a lack of strategies and
confusion in searching for practical solutions to the
question of how to realize the main objectives such as:
patient-centered (ensuring that patient values guide
clinical decisions), effective (evidence-based), efficient
(cost-saving), safe (not-harming) and equitable (without
preferences in access) care (32).
Growing awareness shows that systemic and sustained
cooperation between all healthcare sectors, at the local, re-
gional and national levels, will be necessary to establish
desired vision of the health of the population. This may be
achieved through mechanisms such as: common leader-
ship, medicine oriented on quality and outcomes, com-
prehensive programmes of care supported by shared funds
as well as through changes in the education of profession-
als on ways they can obtain more information from public
health and community resources and be able to take on
leadership roles in health initiatives in the community (1,
3, 27). Politicians should change their way of thinking, by
making decisions which are compatible with the goals
pointed out in health declarations and the health policy
agenda (1, 3). Unexploited potentials of family medicine
have already been recognized. Emphasis is put on the role
of family medicine in the integration of care, the wise use
of resources, accessibility, direct communication with the
community and adaptability on changes in the local envi-
ronment (32).
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Figure 1. Present state of the Health Care System organization. Poorly coordinated and communicated sectors.
Figure 2. The Health Care System of the future. Functionally integrated sectors with the Central Intelligence Unit.




It is possible to imagine the way the health care system
will be organized in the near future. Emphasis will be
put on the prevention of diseases and preservation and
improvement of the health of individuals and the popu-
lation as a whole. The challenges will be in finding out
how to prevent or delay the progress of complex aging
diseases. Common information and communication
technology infrastructure will be necessary for the sys-
temic implementation of the programmed approach in
prevention. That means that all stages of the programme's
performance are known in advance. Implementation of
the programme is based on the collaborative work of in-
terdisciplinary teams. The programme is designed de-
pending on the aims, already identified, and expected
outcomes, and is not limited to the level of the health care
system organization, type of data, or the method of re-
search. To realize this approach, the health care system
should be functionally integrated, with all components
communicating with each other and with a central intel-
ligence unit (Figure 2).
Experts in different fields of medicine, mathemati-
cians, computer science theoreticians, programme design-
ers and health managements will cooperate there, per-
forming activities such as: integration of data collected
from different sectors of the health care system, compari-
son of the data provided from the practice with evidence
based on existing knowledge, quality indicators develop-
ment and preventive programme design (Figure 2).
Regarding population oriented preventive program-
mes, data from local public health service registers will
be used, demonstrating characteristics of the population
of interest. Data of different types will be collected, in-
cluding new parameters such as those indicating genetic,
cultural, societal and environmental characteristics of
the population. For preventive programmes oriented to
specific subgroups of patients or individually oriented
programmes, data collected in the primary health care
practice will be used, enriched by data in genetics,
proteomics, metabolomics (provided by the basic science
and molecular biology) and population-based data on
common societal and environmental characteristics
(provided by the public health services). Clinical medi-
cine will be oriented on detailed diagnostics and person-
alized treatment, based on advances in biotechnology
and molecular biology (basic sciences as a source) and
using data on population genetics and population biol-
ogy markers (public health as a source) and on family
traits and personal characteristics of an individual (pri-
mary health care and family medicine as a source).
If we want to implement such creative medicine in
daily practice, sustained efforts in data collecting and
analysis will be needed. The emphasis should be put on
developing new techniques in data analysis such as the
extraction of new knowledge from databases and
non-linear mathematics and computer-modeling (33,
34, 35). Such medicine will be cost effective, based on ev-
idence, individually-oriented and adopted on the specific
features of the population of interest. In such ideal cir-
cumstances, prevention, research and the best practice
will converge onto the same discipline.
COMMENT ON THE STATE IN CROATIA
At the threshold of the 21st century, the health care sys-
tem in Croatia, as in other Central and SEE ex-socialist
countries, was faced with the transitional process of re-
structuring. Positive predisposition, inherited from the
past, was relatively developed in the health care infrastruc-
ture and the primary health care system was respected in
Europe because of its favourable performance and a long
tradition. As an illustration, Andrija [tampar was one of
the founders of the World Health Organization and the
Chairman of its first General Assembly. Zagreb School of
Public Health was the founder of the Association of
Schools of Public Health in Europe – ASPHER. Family
medicine specialist training was introduced in 1964, for
the first time in the world. International training courses
for primary health care managers took place at Zagreb
School of Public Health from 1978 to 1996 (2, 36, 37, 38).
However, Croatia experienced a war in 1991/92 and
its devastating consequences for the economy, health fa-
cilities and human resources. New types of health prob-
lems, related to the large number of displaced persons,
war victims and fast demographic changes, such as diffi-
culties in adaptation, mental disorders and people who
require long rehabilitation, have appeared, especially in
regions directly striken by war (36, 39, 40). In the postwar
period, typical health problems for the transitional coun-
tries, such as unhealthy behavior of the population and
chronic diseases burden, have been exaggerated (36, 41).
Cerebrovascular diseases, for example, have reached
mortality rates significantly above the average for Europe
(42). In cancer statistics, Croatia holds a high unfavour-
able position (43). Based on this evidence, it is obvious
that there is an urgent need for the preventive actions im-
plementation.
A national epidemiologic survey on the spreading of
hypertension, obesity and cardiovascular diseases was
taken (44). However, intervention encompassed only
general advice given by clinicians and experts on the
need for more intensive nonmedical and medical treat-
ment of cases at higher risk across the population. Initia-
tives, planned to cope with behavioral problems such as
smoking, alcohol consumption, inappropriate nutrition,
physical inactivity and drug addiction, were encouraged
and evaluated as high priorities (36, 45). However, these
programmes were not performed in a comprehensive
way and had only partial success due to the lack of
sustainability, adequate monitoring and follow-up of the
results. More attention was paid to the preparations for the
implementation of The National Programme of the Pre-
vention and Early Detection of Breast, Uterus, Colorectal
and Prostate Cancer (46). The Programme started on Oc-
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tober 2006 with the screening of breast cancer and, one
year later, the Programme for early detection of colorectal
cancer was launched (47, 48). The objectives, set up by
The National Programme, are: to decrease prevalence of
risk factors in the population by promotional and educa-
tion activities, to reduce total cancer mortality rates, to in-
crease a ratio of diagnosed localised cancer compared to
the advanced stage disease and to increase early detection
coverage of the population. The Croatian Public Health
Institute, in collaboration with its county departments, is
responsible for the monitoring of the Programme imple-
mentation, invitation organization, media campaign and
the evaluation of the Programme results (46).
All of these preventive programmes, mentioned above,
have been carried out by public health institutes, alone, or
in collaboration with clinics and health centers, which all
are state and county owned (36). Nongovernmental orga-
nizations, such as The League Against Cancer, have been
directly involved in some actions, as partners (49). Family
physicians have not been formally included in preventive
programmes. The reason why they are rather deprived of
their historical role in performing preventive measures is
that family medicine has gained the specific position in
the health care system through the process of privatiza-
tion of primary health care (36). In the present situation,
family physicians and other primary health care practi-
tioners such as outpatient pediatricians, primary gyne-
cologists and dentists, are not employees of the Health
Center, as they were before, but work in their own enter-
prises, according to the contract with the Croatian Insti-
tute for Health Insurance. Renting facilities is the only
connection with Health Centers, formerly integrated in-
stitutions responsible for providing primary health care
services. Today they are more similar to outpatient clin-
ics.
An idea which preceded the process of privatization of
primary health care was to develop decentralized and pa-
tient-oriented primary health care and to stimulate the
competition between physicians by introducing the capi-
tation fee payment system. The gatekeeping function of
family physicians had to be reinforced by establishing a
three-year postgraduate training programme in family
medicine (36). However, an early intention to rearticu-
late the competencies of family physicians in a fashion
that they play a central role in a sustained partnership
with patients has become a little frustrating. The health
care system as a whole is under the permanent pressure
of scarce resources, based on the low-income economy.
There is an aspiration of the secondary health care to im-
plement new technologies, ensuring the quality stan-
dards. On the contrary, there is an increasing demand for
public services to resolve the problem of unhealthy be-
havior of the population and the growing chronic disease
burden. Inefficient management has allowed adminis-
trative decision makers to take control. In such a situa-
tion, the role of family physicians is more like that of
gatekeepers standing between their patients and care
rather than being able to serve patients as gateways to ap-
propriate care.
A very recent initiative to establish The Commitee for
Primary Health Care at The Ministry of Health reflects a
need for the changes. Great expectations were recently put
on the process of informatisation of primary health care
(50, 51, 52, 53). This process is part of a more ambitious
plan to develop a common e-Health infrastructure by
linking all health care sectors to the central information
system. Major short-term benefits are expected in shorten-
ing the time needed for collecting data for administrative
purposes and in the rationalisation in prescribing medica-
tions. In the long run, focus will be put on making qual-
ity-measure indicators and on developing the integrated
and communicable health care system. Finally, this pro-
cess leads the way for the implementation of comprehen-
sive and cost-effictive health programmes, involving pro-
fessionals from various levels of the health care system.
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